Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 38-44

  Bschor, Tom ^a,b,c   Uhr, Manfred ^d   Baethge, Christopher ^e   Lewitzka, Ute ^b,c,f   Ising, Marcus ^d   Erbe, Sebastian ^a   Winkelmann, Patricia ^b   Ritter, Dirk ^b  

^a Schlosspark Clinic   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c International Group for the Study of Lithium Treated Patients (IGSLI)   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

citalopram; lithium; major depression; recurrent course; single episode

Indexed keywords

CITALOPRAM; LITHIUM CARBONATE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHI-SQUARE DISTRIBUTION; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873096046     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31827b9495     Document Type: Article

References (42)

1. NICE-National Collaborating Centre for Mental Health. Depression: Management of depression in primary and secondary care. Clinical Practice Guideline. 2006;23. Available at: http://www.nice.org.uk/nicemedia/pdf/ CG23fullguideline.pdf. Accessed January 4, 2011.
2. Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8(2):67-104.
3. Bschor T, Adli M. Treatment of depressive disorders. Dtsch Arztebl Int. 2008;105:782-792.
4. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
5. Bschor T, Baethge C. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatr Scand. 2010;121(3):174-179.
6. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55-68.
7. Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry: The Comprehensive Guide. London, UK: Informa Healthcare; 2006.
8. Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des. 2006;12(23):2985-2992.
9. Mendels J, Secunda SK, Dyson WL. A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry. 1972;26(2):154-157.
10. Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiatry. 1975;32(5):659-668.
11. Khan MC. Lithium carbonate in the treatment of acute depressive illness. Bibliotheca Psychiatrica. 1981;(161):244-248.
12. Arieli A, Lepkifker E. The antidepressant effect of lithium. Curr Dev Psychopharmacol. 1981;6:165-190.
13. Linder J, Fyro B, Pettersson U, et al. Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double-blind study on the antidepressant effect of lithium and clomipramine. Acta Psychiatr Scand. 1989;80(1):27-36.
14. Worrall EP, Moody JP, Peet M, et al. Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry. 1979;135:255-262.
15. Khan MC, Wickham EA, Reed JV. Lithium versus placebo in acute depression: a clinical trial. Int Clin Psychopharmacol. 1987;2(1):47-54.
16. Adli M, Bschor T, Canata B, et al. [Lithium in the treatment of acute depression]. Fortschr Neurol Psychiatr. 1998;66(10):435-441.
17. Bschor T, Ritter D, Winkelmann P, et al. Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients. PLoS One. 2011;6(11):e27613.
18. Bschor T, Ising M, Erbe S, et al. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients. J Psychiatr Res. 2012;46(1):111-117.
19. Spitzer RL, Williams JB, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624-629.
20. Williams JB, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49(8):630-636.
21. Segal DL, Hersen M, Van Hasselt VB. Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review. Compr Psychiatry. 1994;35(4):316-327.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Loh A, Leonhart R, Wills CE, et al. The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Educ Couns. 2007;65(1):69-78.
24. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
25. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
26. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR&z.ast;D) study. Psychiatr Clin North Am. 2003;26(2):457-494.
27. Rybakowski JK. Lithium in neuropsychiatry: a 2010 update. World J Biol Psychiatry. 2011.
28. Nivoli AM, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology. 2010; 62(1):27-35.
29. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord. 2009;11(suppl 2):77-83.
30. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet. 2002;359(9302):241-247.
31. Perlis RH, Uher R, Ostacher M, et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiatry. 2011;68(4):351-360.
32. Akiskal HS, Benazzi F. The DSM-IVand ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. J Affect Disord. 2006;92(1):45-54.
33. Correa R, Akiskal H, Gilmer W, et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2010;127(1-3):10-18.
34. Mantere O, Suominen K, Arvilommi P, et al. Clinical predictors of unrecognized bipolar I and II disorders. Bipolar Disord. 2008;10(2):238-244.
35. Benazzi F. Misdiagnosis of bipolar II disorder as major depressive disorder. J Clin Psychiatry. 2008;69(3):501-502; author reply 502-503.
36. Frye MA. Clinical practice. Bipolar disorderVa focus on depression. N Engl J Med. 2011;364(1):51-59.
37. Baldessarini RJ, Vieta E, Calabrese JR, et al. Bipolar depression: overview and commentary. Harv Rev Psychiatry. 2010;18(3):143-157.
38. Bowden CL. Treatment strategies for bipolar depression. J Clin Psychiatry. 2010;71(5):e10.
39. Baron M, Gershon ES, Rudy V, et al. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry. 1975;32(9):1107-1111.
40. Muller-Oerlinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology. 2010;62(1):43-49.
41. Guzzetta F, Tondo L, Centorrino F, et al. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007;68(3):380-383.
42. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003;64(suppl 5):44-52.